Notifications
Back

Investor Relations

OSR Holdings, an Open and Socially Responsible Healthcare Group

Investor Relations

OSR Holdings, an Open and Socially Responsible Healthcare Group


OSR Holdings, Inc. (NASDAQ: OSRH) is a healthcare-focused holding company committed to building long-term shareholder value through strategic investment in immuno-oncology, regenerative biologics, and medical device technologies.

Latest News

OSR Holdings Eliminates $2.02 Million Warrant Overhang with Premium-Priced Convertible Note OSR Holdings Eliminates $2.02 Million Warrant Overhang with Premium-Priced Convertible Note
9 Apr 2026
OSR Holdings to Update Investors at the Emerging Growth Conference on April 1, 2026 OSR Holdings to Update Investors at the Emerging Growth Conference on April 1, 2026
30 Mar 2026
Emerging Growth Research Issues Flash Report on OSR Holdings, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target Emerging Growth Research Issues Flash Report on OSR Holdings, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target
27 Mar 2026
OSR Holdings Updates $815 Million VXM01 Licensing Deal Structure to Capture Value at Parent Level OSR Holdings Updates $815 Million VXM01 Licensing Deal Structure to Capture Value at Parent Level
23 Mar 2026
Woori IO, an OSR Company, Signs NDA with Sinopharm for China Market and Global Multicenter Trials Woori IO, an OSR Company, Signs NDA with Sinopharm for China Market and Global Multicenter Trials
19 Mar 2026
OSR Holdings, Inc. Granted 180-Day Nasdaq Extension; Reaffirms Strategic Momentum OSR Holdings, Inc. Granted 180-Day Nasdaq Extension; Reaffirms Strategic Momentum
5 Mar 2026
CEO Statement to Shareholders CEO Statement to Shareholders
2 Feb 2026
OSR Holdings Completes Woori IO Acquisition, Secures Long-Term Shareholder Alignment, and Reviews Strategic Combination of Medical Device Subsidiaries OSR Holdings Completes Woori IO Acquisition, Secures Long-Term Shareholder Alignment, and Reviews Strategic Combination of Medical Device Subsidiaries
27 Jan 2026
Woori IO, an OSR Company, Highlights FDA Clarification on Non-Medical Wearables as a Catalyst for Accelerated Commercial Launch Woori IO, an OSR Company, Highlights FDA Clarification on Non-Medical Wearables as a Catalyst for Accelerated Commercial Launch
22 Jan 2026
Vaximm Appoints Sébastien Wieckowski, PhD, as Chief Scientific Officer to Advance Next-Generation Oral Immunotherapy Platform Vaximm Appoints Sébastien Wieckowski, PhD, as Chief Scientific Officer to Advance Next-Generation Oral Immunotherapy Platform
16 Jan 2026


OSR Holdings, Inc. (NASDAQ: OSRH) is a healthcare-focused holding company committed to building long-term shareholder value through strategic investment in immuno-oncology, regenerative biologics, and medical device technologies.


Latest News

OSR Holdings　　Reg No. 589-86-01485

Email: ir@osr-holdings.com


US: 10900 NE 4th Street, 2300 Bellevue, WA 98004
KR: B-dong, 3F, 37-36 Hoedong-gil, Paju-si, Gyeonggi-do
CH: Technologiepark Basel, Hochbergerstrasse 60c

Copyright © OSR Holdings, Inc. All Rights Reserved.



              

OSR Holdings, Inc.　　Reg No. 589-86-01485　　Email: ir@osr-holdings.com

U.S  10900 NE 4th Street, 2300 Bellevue, WA 98004

Korea, Republic of  B-dong, 3F, 37-36 Hoedong-gil, Paju-si, Gyeonggi-do 
Switzerland  Technologiepark Basel, Hochbergerstrasse 60c, CH-4057


Copyright © OSR Holdings, Inc. All Rights Reserved.